Safety of intracameral application of moxifloxacin and dexamethasone (Vigadexa®) after phacoemulsification surgery.

Virgilio GalvisAngelica Maria PradaAlejandro TelloMaria Margarita ParraPaul Anthony CamachoMaría Paz Polit

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2023)

The endothelial cell loss after the intracameral use of Vigadexa® at the end of cataract surgery was similar to the reported in other studies of cataract surgery without the use of intracameral prophylaxis for postoperative endophthalmitis (POE). This study confirmed the association of CDE and nuclear opalescence grade with postoperative corneal endothelial cell loss.

Keyphrases

cataract surgery
endothelial cells
patients undergoing
minimally invasive
coronary artery bypass
high glucose
low dose
high dose
coronary artery disease
surgical site infection